Serum CCL11/eotaxin and IL-6 allow differentiation between patients with chronic recurrent multifocal osteomyelitis (CRMO), healthy controls, and alternative diagnoses. Here, CCL11 is linked to chronic recurrent multifocal osteomyelitis.